ARCHIVES

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

This article is from The Cancer Letter archive.

Vol. 34 No. 41 | November 7, 2008

Download PDF Visit The Full Archive

Related Articles

Nexavar Improves PFS In HER-2 Negative Breast Cancer

May 27, 2011

US, Italy Plan Greater Scientific Collaboration

May 16, 2003

In Brief: Cancer Act, Accelerated Progress, ACS President Says; Scanners Scapegoats, EMI Chief Claimes

April 7, 1978

Wichita CCOP Stopped Accrual For Two Months, PI Says.

May 12, 2006

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004

In Brief: Carcinogenesis Task Force to Wrap Up Review In Four-Six Weeks; UCLA Groundbreaking Set

October 28, 1977